Xtl Biopharmaceuticals Ltd (XTLB) — 20-F Filings
All 20-F filings from Xtl Biopharmaceuticals Ltd. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
XTL Biopharmaceuticals Files 2024 Annual Report
— Apr 30, 2025 Risk: medium
XTL Biopharmaceuticals Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, incorporated in Israel, is listed und -
XTL Biopharmaceuticals Ltd. Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2023
— Apr 30, 2024 Risk: low
XTL BIOPHARMACEUTICALS LTD (XTLB) filed a Foreign Annual Report (20-F) with the SEC on April 30, 2024. XTL Biopharmaceuticals Ltd. filed its annual report on Fo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX